Role of homoeopathic medicines in the treatment of chronic rhinosinusitis.

To Explore the Effectiveness of Individualized Homoeopathic medicines vs Saline Nasal Irrigation (Jalneti) in Treatment of Chronic Rhinosinusitis: A Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093642

Enrollment

Registered

2025-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J32- Chronic sinusitis

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: HOMOEOPATHIC MEDICINE WILL BE ADMINISTERED IN CENTESIMAL POTENCIES, SELECTED ACCORDING TO HOMOEOPATHIC PRINCIPLES. THE DOSE AND REPETITION WILL BE DECIDED AS PER

Eligibility

Inclusion criteria

Inclusion criteria: 1. Persons having symptoms of sinusitis for more than 12 weeks 2. Both sexes of age group above 18 years and below 60 years. 3. Persons having symptoms of chronic rhinosinusitis clinically as well as with x ray studies suggestive of sinusitis will be included 4. Persons having sinusitis irrespective of the association with other diseases like asthma, allergic rhinitis, nasal polyps will be included.

Exclusion criteria

Exclusion criteria: 1. Persons suffering from systemic illness with life threatening complications. 2. Persons suffering with complications of sinusitis with severe obstruction of nose due to DNS in need of surgical interventions. 3. Persons already undergoing homoeopathic treatment for any chronic disease without washout period for atleast 2 weeks. 4. pregnant or lactating women , patients with psychiatric disease , and those with immunocompromised state are to be excluded.

Design outcomes

Primary

Measure	Time frame
The trial is expected to indicate that individualized homeopathic medicine will yield better results than saline nasal irrigation (Jalneti) in the treatment of chronic rhinosinusitis.Timepoint: 1 year (12 months)	—

Secondary

Measure	Time frame
1. The study is expected to demonstrate improved patient quality of life, evaluated subjectively using the SNOT-22 questionnaire in patients of chronic rhinosinusitis. 2. At the end of study it is expected that the radiographic findings of paranasal sinuses will show improvement following the treatment. 3. This research aims to identify most commonly indicated homoeopathic medicines in treatment of chronic rhinosinusitis. 4. It is expected that there may be subjective (symptomatic) and objective (X-Ray paranasal sinuses) improvement along with improvement in general well-being, without any substantial medicinal adverse effects.Timepoint: 1 year(12 months)	—

Measure

Time frame

1. The study is expected to demonstrate improved patient quality of life, evaluated subjectively using the SNOT-22 questionnaire in patients of chronic rhinosinusitis. 2. At the end of study it is expected that the radiographic findings of paranasal sinuses will show improvement following the treatment. 3. This research aims to identify most commonly indicated homoeopathic medicines in treatment of chronic rhinosinusitis. 4. It is expected that there may be subjective (symptomatic) and objective (X-Ray paranasal sinuses) improvement along with improvement in general well-being, without any substantial medicinal adverse effects.Timepoint: 1 year(12 months)

—

Countries

India

Contacts

Public ContactDr Ayushi Gupta

Dr BR Sur Homoeopathic Medical College, Hospital and Research Centre

drrajivh@yahoo.co.in7994273285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026